sglt2 and glp 1 combination Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys the Brain SGLT-2 Inhibitors and GLP-1 Agonists:

In addition, people who have a prior serious hypersensitivity reaction to liraglutide or any of the product components should not use liraglutide

Fenugreek compound (N55) lowers plasma glucose through the enhancement of response of physiological glucagon-like peptide-1

Once FDA establishes the intended use, FDA can review its own records to determine that the company is not registered with FDA and/or has no drug approval, at which point the product is an unapproved new drug. Adulteration and misbranding violations follow in line, both of which are based on statutes carrying civil and criminal penalties

The clinical outcomes differ dramatically